Chemical
Browse
Active Pharmaceutical Ingredients
Bioactive chemicals
Agrochemicals
Search
Chemical Structure
Explore
Chemical Similarity
Transformation
Browse
Prodrugs
Drug Metabolites
Metabolite Datasets
Cytochrome P450
Homo sapiens »
CYP1
CYP2
CYP3
CYP4
CYP5
CYP7
CYP8
CYP11
CYP17
CYP19
CYP20
CYP21
CYP24
CYP26
CYP27
CYP39
CYP46
CYP51
Mus musculus
Danio rerio
Oncorhynchus mykiss
Comparison of CYPs
Biochemical Action
Browse
Target Level (ChEMBL)
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Mechanism of action
Search
Mechanism of action
BLAST against human drug target
BLAST against selected species (UniProt)
Exposure
Browse
Monitoring data
Downloads
Web services
Bulk downloads
About
About EcoDrug+
Citing
Data Sources
FAQ
Contact Us
Versions
Display Options:
Molecule Type
Mechanism of Action
Route of Adminstration
Status
Therapeutic Indication
Number of compounds:
7959
ZOLEDRONIC ACID
(2001)
Small molecule
Farnesyl diphosphate synthase inhibitor
INJECTION; INTRAVENOUS; IV (INFUSION)
Approved
Bone Diseases; Multiple Myeloma; Neoplasm Metastasis; Osteitis Deformans; Osteoporosis; Osteoporosis, Postmenopausal; Prostatic Neoplasms
ZOLEDRONIC ACID
×
Maximum Phase:
4
First Approval:
2001
UNII:
6XC1PAD3KF
Molecule Type:
Small molecule
Molecular Formula:
C5H10N2O7P2
Molecular Weight:
272.09
AlogP:
-1.12
PSA:
153.11
HBD:
5.0
HBA:
#RotB:
4.0
Source:
VALGANCICLOVIR
(2001)
Small molecule
Unknown
Unknown
Approved
Virus Diseases
VALGANCICLOVIR
×
Maximum Phase:
4
First Approval:
2001
UNII:
GCU97FKN3R
Molecule Type:
Small molecule
Molecular Formula:
C14H22N6O5
Molecular Weight:
354.37
AlogP:
-1.44
PSA:
171.37
HBD:
4.0
HBA:
#RotB:
8.0
Source:
CASPOFUNGIN ACETATE
(2001)
Small molecule
1,3-beta-glucan synthase inhibitor
INTRAVENOUS
Approved
Aspergillosis; Candidemia; Candidiasis; Mycoses
CASPOFUNGIN ACETATE
×
Maximum Phase:
4
First Approval:
2001
UNII:
VUW370O5QE
Molecule Type:
Small molecule
Molecular Formula:
C56H96N10O19
Molecular Weight:
1213.43
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
NORELGESTROMIN
(2001)
Small molecule
Progesterone receptor agonist
Unknown
Approved
Unknown
NORELGESTROMIN
×
Maximum Phase:
4
First Approval:
2001
UNII:
R0TAY3X631
Molecule Type:
Small molecule
Molecular Formula:
C21H29NO2
Molecular Weight:
327.47
AlogP:
4.14
PSA:
52.82
HBD:
2.0
HBA:
#RotB:
1.0
Source:
ZIPRASIDONE HYDROCHLORIDE
(2001)
Small molecule
Dopamine D2 receptor antagonist
ORAL
Approved
Arrhythmias, Cardiac; Bipolar Disorder; Mental Disorders; Schizophrenia; Tachycardia, Ventricular
ZIPRASIDONE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
2001
UNII:
216X081ORU
Molecule Type:
Small molecule
Molecular Formula:
C21H24Cl2N4O2S
Molecular Weight:
467.42
AlogP:
3.81
PSA:
48.47
HBD:
1.0
HBA:
#RotB:
4.0
Source:
ZIPRASIDONE
(2001)
Small molecule
Unknown
Unknown
Approved
Psychotic Disorders
ZIPRASIDONE
×
Maximum Phase:
4
First Approval:
2001
UNII:
6UKA5VEJ6X
Molecule Type:
Small molecule
Molecular Formula:
C21H21ClN4OS
Molecular Weight:
412.95
AlogP:
3.81
PSA:
48.47
HBD:
1.0
HBA:
#RotB:
4.0
Source:
TENOFOVIR DISOPROXIL FUMARATE
(2001)
Small molecule
Human immunodeficiency virus type 1 reverse transcriptase inhibitor
ORAL
Approved
HIV Infections; Hepatitis B, Chronic; Infections; Liver Diseases
TENOFOVIR DISOPROXIL FUMARATE
×
Maximum Phase:
4
First Approval:
2001
UNII:
OTT9J7900I
Molecule Type:
Small molecule
Molecular Formula:
C23H34N5O14P
Molecular Weight:
635.52
AlogP:
3.04
PSA:
185.44
HBD:
1.0
HBA:
#RotB:
13.0
Source:
ETHINYL ESTRADIOL
(2001)
Small molecule
Estrogen receptor alpha agonist
ORAL
Approved
Acne Vulgaris; Neoplasms
ETHINYL ESTRADIOL
×
Maximum Phase:
4
First Approval:
2001
UNII:
423D2T571U
Molecule Type:
Small molecule
Molecular Formula:
C20H24O2
Molecular Weight:
296.41
AlogP:
3.61
PSA:
40.46
HBD:
2.0
HBA:
#RotB:
0.0
Source:
FROVATRIPTAN
(2001)
Small molecule
Unknown
Unknown
Approved
Migraine Disorders
FROVATRIPTAN
×
Maximum Phase:
4
First Approval:
2001
UNII:
H82Q2D5WA7
Molecule Type:
Small molecule
Molecular Formula:
C14H17N3O
Molecular Weight:
243.31
AlogP:
1.34
PSA:
70.91
HBD:
3.0
HBA:
#RotB:
2.0
Source:
FORMOTEROL
(2001)
Small molecule
Unknown
Unknown
Approved
Lung Diseases, Obstructive
FORMOTEROL
×
Maximum Phase:
4
First Approval:
2001
UNII:
5ZZ84GCW8B
Molecule Type:
Small molecule
Molecular Formula:
C19H24N2O4
Molecular Weight:
344.41
AlogP:
2.22
PSA:
90.82
HBD:
4.0
HBA:
#RotB:
9.0
Source:
FORMOTEROL FUMARATE
(2001)
Small molecule
Beta-2 adrenergic receptor agonist
INHALATION
Approved
Asthma; Bronchial Spasm; Bronchitis, Chronic; Emphysema; Pulmonary Disease, Chronic Obstructive
FORMOTEROL FUMARATE
×
Maximum Phase:
4
First Approval:
2001
UNII:
W34SHF8J2K
Molecule Type:
Small molecule
Molecular Formula:
C42H56N4O14
Molecular Weight:
840.92
AlogP:
2.22
PSA:
90.82
HBD:
4.0
HBA:
#RotB:
9.0
Source:
ERTAPENEM SODIUM
(2001)
Small molecule
Bacterial penicillin-binding protein inhibitor
INTRAMUSCULAR; INTRAVENOUS
Approved
Infections; Intraabdominal Infections; Osteomyelitis
ERTAPENEM SODIUM
×
Maximum Phase:
4
First Approval:
2001
UNII:
2T90KE67L0
Molecule Type:
Small molecule
Molecular Formula:
C22H24N3NaO7S
Molecular Weight:
497.51
AlogP:
0.94
PSA:
156.27
HBD:
5.0
HBA:
#RotB:
7.0
Source:
TENOFOVIR DISOPROXIL
(2001)
Small molecule
Unknown
Unknown
Approved
Virus Diseases
TENOFOVIR DISOPROXIL
×
Maximum Phase:
4
First Approval:
2001
UNII:
F4YU4LON7I
Molecule Type:
Small molecule
Molecular Formula:
C19H30N5O10P
Molecular Weight:
519.45
AlogP:
3.04
PSA:
185.44
HBD:
1.0
HBA:
#RotB:
13.0
Source:
GALANTAMINE
(2001)
Small molecule
Unknown
Unknown
Approved
Dementia
GALANTAMINE
×
Maximum Phase:
4
First Approval:
2001
UNII:
0D3Q044KCA
Molecule Type:
Small molecule
Molecular Formula:
C17H21NO3
Molecular Weight:
287.36
AlogP:
1.85
PSA:
41.93
HBD:
1.0
HBA:
#RotB:
1.0
Source:
VALGANCICLOVIR HYDROCHLORIDE
(2001)
Small molecule
Human herpesvirus 1 DNA polymerase inhibitor
ORAL
Approved
Acquired Immunodeficiency Syndrome; Cytomegalovirus Retinitis; Retinitis
VALGANCICLOVIR HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
2001
UNII:
4P3T9QF9NZ
Molecule Type:
Small molecule
Molecular Formula:
C14H23ClN6O5
Molecular Weight:
390.83
AlogP:
-1.44
PSA:
171.37
HBD:
4.0
HBA:
#RotB:
8.0
Source:
DUTASTERIDE
(2001)
Small molecule
Steroid 5-alpha-reductase inhibitor
ORAL
Approved
Prostatic Hyperplasia; Prostatic Neoplasms
DUTASTERIDE
×
Maximum Phase:
4
First Approval:
2001
UNII:
O0J6XJN02I
Molecule Type:
Small molecule
Molecular Formula:
C27H30F6N2O2
Molecular Weight:
528.54
AlogP:
6.58
PSA:
58.2
HBD:
2.0
HBA:
#RotB:
2.0
Source:
DESLORATADINE
(2001)
Small molecule
Histamine H1 receptor antagonist
ORAL
Approved
Hypersensitivity; Rhinitis, Allergic, Seasonal; Urticaria
DESLORATADINE
×
Maximum Phase:
4
First Approval:
2001
UNII:
FVF865388R
Molecule Type:
Small molecule
Molecular Formula:
C19H19ClN2
Molecular Weight:
310.83
AlogP:
4.02
PSA:
24.92
HBD:
1.0
HBA:
#RotB:
0.0
Source:
VALDECOXIB
(2001)
Small molecule
Cyclooxygenase-2 inhibitor
ORAL
Approved
Rheumatic Diseases
VALDECOXIB
×
Maximum Phase:
4
First Approval:
2001
UNII:
2919279Q3W
Molecule Type:
Small molecule
Molecular Formula:
C16H14N2O3S
Molecular Weight:
314.37
AlogP:
2.96
PSA:
86.19
HBD:
1.0
HBA:
#RotB:
3.0
Source:
IMATINIB
(2001)
Small molecule
Unknown
Unknown
Approved
Neoplasms
IMATINIB
×
Maximum Phase:
4
First Approval:
2001
UNII:
BKJ8M8G5HI
Molecule Type:
Small molecule
Molecular Formula:
C29H31N7O
Molecular Weight:
493.62
AlogP:
4.59
PSA:
86.28
HBD:
2.0
HBA:
#RotB:
7.0
Source:
ALMOTRIPTAN
(2001)
Small molecule
Unknown
Unknown
Approved
Migraine Disorders
ALMOTRIPTAN
×
Maximum Phase:
4
First Approval:
2001
UNII:
1O4XL5SN61
Molecule Type:
Small molecule
Molecular Formula:
C17H25N3O2S
Molecular Weight:
335.47
AlogP:
2.2
PSA:
56.41
HBD:
1.0
HBA:
#RotB:
6.0
Source:
CEFDITOREN PIVOXIL
(2001)
Small molecule
Bacterial penicillin-binding protein inhibitor
ORAL
Approved
Bronchitis, Chronic; Infections; Pharyngitis; Tonsillitis
CEFDITOREN PIVOXIL
×
Maximum Phase:
4
First Approval:
2001
UNII:
78THA212DH
Molecule Type:
Small molecule
Molecular Formula:
C25H28N6O7S3
Molecular Weight:
620.74
AlogP:
2.3
PSA:
175.4
HBD:
2.0
HBA:
#RotB:
9.0
Source:
TRAVOPROST
(2001)
Small molecule
Prostanoid FP receptor agonist
OPHTHALMIC
Approved
Glaucoma; Glaucoma, Open-Angle; Ocular Hypertension
TRAVOPROST
×
Maximum Phase:
4
First Approval:
2001
UNII:
WJ68R08KX9
Molecule Type:
Small molecule
Molecular Formula:
C26H35F3O6
Molecular Weight:
500.55
AlogP:
4.43
PSA:
96.22
HBD:
3.0
HBA:
#RotB:
12.0
Source:
DROSPIRENONE
(2001)
Small molecule
Mineralocorticoid receptor antagonist
ORAL
Approved
Acne Vulgaris
DROSPIRENONE
×
Maximum Phase:
4
First Approval:
2001
UNII:
N295J34A25
Molecule Type:
Small molecule
Molecular Formula:
C24H30O3
Molecular Weight:
366.5
AlogP:
4.31
PSA:
43.37
HBD:
0.0
HBA:
#RotB:
0.0
Source:
BIMATOPROST
(2001)
Small molecule
Prostanoid FP receptor agonist
OPHTHALMIC; TOPICAL
Approved
Glaucoma; Glaucoma, Open-Angle; Hypotrichosis; Ocular Hypertension
BIMATOPROST
×
Maximum Phase:
4
First Approval:
2001
UNII:
QXS94885MZ
Molecule Type:
Small molecule
Molecular Formula:
C25H37NO4
Molecular Weight:
415.57
AlogP:
3.15
PSA:
89.79
HBD:
4.0
HBA:
#RotB:
12.0
Source:
ALMOTRIPTAN MALATE
(2001)
Small molecule
Serotonin 1b (5-HT1b) receptor agonist
ORAL
Approved
Migraine Disorders
ALMOTRIPTAN MALATE
×
Maximum Phase:
4
First Approval:
2001
UNII:
PJP312605E
Molecule Type:
Small molecule
Molecular Formula:
C21H31N3O7S
Molecular Weight:
469.56
AlogP:
2.2
PSA:
56.41
HBD:
1.0
HBA:
#RotB:
6.0
Source:
CASPOFUNGIN
(2001)
Small molecule
Unknown
Unknown
Approved
Unknown
CASPOFUNGIN
×
Maximum Phase:
4
First Approval:
2001
UNII:
F0XDI6ZL63
Molecule Type:
Small molecule
Molecular Formula:
C52H88N10O15
Molecular Weight:
1093.33
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
DEXMETHYLPHENIDATE HYDROCHLORIDE
(2001)
Small molecule
Dopamine transporter inhibitor
ORAL
Approved
Attention Deficit Disorder with Hyperactivity
DEXMETHYLPHENIDATE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
2001
UNII:
1678OK0E08
Molecule Type:
Small molecule
Molecular Formula:
C14H20ClNO2
Molecular Weight:
269.77
AlogP:
2.09
PSA:
38.33
HBD:
1.0
HBA:
#RotB:
3.0
Source:
BOSENTAN
(2001)
Small molecule
Endothelin receptor, ET-A/ET-B antagonist
Unknown
Approved
Familial Primary Pulmonary Hypertension; Heart Defects, Congenital; Hypertension; Hypertension, Pulmonary; Pulmonary Arterial Hypertension
BOSENTAN
×
Maximum Phase:
4
First Approval:
2001
UNII:
Q326023R30
Molecule Type:
Small molecule
Molecular Formula:
C27H29N5O6S
Molecular Weight:
551.63
AlogP:
4.2
PSA:
145.65
HBD:
2.0
HBA:
#RotB:
10.0
Source:
TOCOPHEROL ACETATE
(2001)
Small molecule
Unknown
Unknown
Approved
Unknown
TOCOPHEROL ACETATE
×
Maximum Phase:
4
First Approval:
2001
UNII:
9E8X80D2L0
Molecule Type:
Small molecule
Molecular Formula:
C31H52O3
Molecular Weight:
472.75
AlogP:
9.06
PSA:
35.53
HBD:
0.0
HBA:
#RotB:
13.0
Source:
FROVATRIPTAN SUCCINATE
(2001)
Small molecule
Serotonin 1b (5-HT1b) receptor agonist
ORAL
Approved
Migraine Disorders
FROVATRIPTAN SUCCINATE
×
Maximum Phase:
4
First Approval:
2001
UNII:
D28J6W18HY
Molecule Type:
Small molecule
Molecular Formula:
C18H25N3O6
Molecular Weight:
379.41
AlogP:
1.34
PSA:
70.91
HBD:
3.0
HBA:
#RotB:
2.0
Source:
IMATINIB MESYLATE
(2001)
Small molecule
Bcr/Abl fusion protein
ORAL
Approved
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
IMATINIB MESYLATE
×
Maximum Phase:
4
First Approval:
2001
UNII:
8A1O1M485B
Molecule Type:
Small molecule
Molecular Formula:
C30H35N7O4S
Molecular Weight:
589.72
AlogP:
4.59
PSA:
86.28
HBD:
2.0
HBA:
#RotB:
7.0
Source:
ESOMEPRAZOLE
(2001)
Small molecule
Unknown
Unknown
Approved
Gastroesophageal Reflux; Peptic Ulcer
ESOMEPRAZOLE
×
Maximum Phase:
4
First Approval:
2001
UNII:
N3PA6559FT
Molecule Type:
Small molecule
Molecular Formula:
C17H19N3O3S
Molecular Weight:
345.42
AlogP:
2.9
PSA:
77.1
HBD:
1.0
HBA:
#RotB:
5.0
Source:
GALANTAMINE HYDROBROMIDE
(2001)
Small molecule
Acetylcholinesterase inhibitor
ORAL
Approved
Alzheimer Disease; Dementia
GALANTAMINE HYDROBROMIDE
×
Maximum Phase:
4
First Approval:
2001
UNII:
MJ4PTD2VVW
Molecule Type:
Small molecule
Molecular Formula:
C17H22BrNO3
Molecular Weight:
368.27
AlogP:
1.85
PSA:
41.93
HBD:
1.0
HBA:
#RotB:
1.0
Source:
PERFLUTREN
(2001)
Small molecule
Diagnostic agent
INTRAVENOUS
Approved
Unknown
PERFLUTREN
×
Maximum Phase:
4
First Approval:
2001
UNII:
CK0N3WH0SR
Molecule Type:
Small molecule
Molecular Formula:
C3F8
Molecular Weight:
188.02
AlogP:
2.75
PSA:
0.0
HBD:
0.0
HBA:
#RotB:
0.0
Source:
PIMECROLIMUS
(2001)
Small molecule
FK506-binding protein 1A inhibitor
TOPICAL
Approved
Dermatitis, Atopic; Eczema
PIMECROLIMUS
×
Maximum Phase:
4
First Approval:
2001
UNII:
7KYV510875
Molecule Type:
Small molecule
Molecular Formula:
C43H68ClNO11
Molecular Weight:
810.47
AlogP:
5.72
PSA:
158.13
HBD:
2.0
HBA:
#RotB:
6.0
Source:
ETONOGESTREL
(2001)
Small molecule
Progesterone receptor agonist
Unknown
Approved
Unknown
ETONOGESTREL
×
Maximum Phase:
4
First Approval:
2001
UNII:
304GTH6RNH
Molecule Type:
Small molecule
Molecular Formula:
C22H28O2
Molecular Weight:
324.46
AlogP:
4.05
PSA:
37.3
HBD:
1.0
HBA:
#RotB:
1.0
Source:
1
2
…
51
52
53
54
55
56
57
…
221
222
Next »
Download Option
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA